Filariasis, a parasitic disease caused by filarial worms, affects both humans and animals. Considered a neglected tropical disease (NTD), it is endemic in numerous regions worldwide, particularly in tropical and subtropical areas. This comprehensive overview aims to provide information on the global prevalence of filariasis, its transmission routes, affected populations, key statistics, historical context and discovery, major risk factors associated with transmission, and the impact it has on different regions and populations.

1. Global Prevalence:
   Filariasis is present in approximately 80 countries globally, with an estimated 600 million people at risk of infection. According to the World Health Organization (WHO), there are around 120 million people infected with lymphatic filariasis (LF) and 40 million with onchocerciasis (river blindness), making these two types the most common and significant in terms of public health impact.

2. Transmission Routes:
   Filariasis is transmitted to humans through the bites of infected mosquitoes. Different species of mosquitoes act as vectors for different types of filarial worms, with Aedes, Anopheles, and Culex mosquitoes being the most common. Additionally, filariasis can be transmitted through contact with infected blood or injections involving contaminated needles.

3. Affected Populations:
   Although filariasis can affect individuals of all ages, it is more prevalent in rural agricultural communities with limited access to healthcare and poor sanitation. The disease is most commonly found in tropical and subtropical regions, including South Asia, Sub-Saharan Africa, and parts of the Americas.

4. Key Statistics:
   - Lymphatic filariasis (LF): It is estimated that approximately 120 million people worldwide are infected with LF, with over 1.34 billion people residing in areas at risk of infection.
   - Onchocerciasis (river blindness): Approximately 40 million people are infected with onchocerciasis, and consequently, about 200 million people live in endemic areas.
   - Other types of filariasis, such as loiasis, Mansonella, and Brugia, have a lower global prevalence but still remain significant in specific regions.

5. Historical Context and Discovery:
   Filariasis has been documented for centuries, with evidence of its presence found in ancient Egyptian and Indian texts. The discovery of the causative agents, filarial worms, can be traced back to the 19th century. The recognition of mosquito bites as the primary mode of transmission by Sir Patrick Manson and the demonstration of filarial worms in mosquitoes by Sir Ronald Ross were pivotal breakthroughs in understanding the disease.

6. Major Risk Factors:
   - Mosquito-Borne Transmission: The presence of mosquito vectors significantly contributes to filariasis transmission. Poor vector control measures, standing water, and inadequate use of mosquito nets contribute to the spread of the disease.
   - Poor Sanitation and Hygiene: Inadequate sanitation and hygiene conditions, including open defecation, can lead to increased transmission due to contaminated water sources and heightened mosquito breeding grounds.
   - Poverty and Limited Access to Healthcare: Communities with limited resources and poor access to healthcare services are at higher risk of filariasis due to the lack of preventive measures, diagnosis, and treatment.

7. Impact on Regions and Populations:
   Filariasis greatly impacts affected populations in terms of public health and socio-economic burden. The disease can cause severe disability, including lymphedema, elephantiasis, and visual impairment, resulting in reduced productivity, social stigmatization, and economic losses for individuals and communities.

   Prevalence rates and affected demographics vary among regions. LF is most widespread in South Asia and Sub-Saharan Africa, while onchocerciasis is endemic in parts of Africa, the Americas, and Yemen. 

   Some regions have witnessed successful LF elimination efforts, resulting in reduced prevalence rates. The Global Program to Eliminate Lymphatic Filariasis (GPELF) aims to eliminate the disease as a public health problem by 2020. However, challenges such as limited resources, drug distribution, and program coverage persist.

To conclude, filariasis is a global health challenge that significantly impacts affected populations. Efforts to control and eliminate the disease through preventive measures, vector control, and treatment programs are crucial for reducing its prevalence and minimizing the burden it places on communities.